All articles
Early Menopause Symptoms: What to Watch For and When to Test
Reading time:
9 min
Get expert guidance and a personalized care plan designed around you.
Premature Menopause Means Before 40
Before 40 the term changes, and so does the clinical urgency. Doctors call it premature menopause or primary ovarian insufficiency, usually shortened to POI. The two overlap but are not identical: with POI, ovarian function can fluctuate rather than stop, so occasional periods and even pregnancy remain possible (1).
The risk of POI before 40 is usually put at about 1% (8,9), and it rises steeply with age. One review puts it at roughly 1 in 10,000 women aged 18 to 25, 1 in 1,000 aged 25 to 30, and 1 in 100 aged 35 to 40 (9). The 1% figure has been the standard estimate for years, although a 2019 meta-analysis of 31 studies reported a pooled prevalence of 3.7% (3,10).
The distinction matters because the younger the onset, the longer the body spends without the estrogen it would otherwise have had, and that is what drives the long-term picture below.
Causes Range From Genetic to Unexplained
In most cases no cause is ever identified, which is frustrating but worth knowing in advance (1). Where a cause is found, MedlinePlus (1) and Mayo Clinic (7) describe a familiar set.
Genetic conditions: Turner syndrome and Fragile X syndrome both raise the risk, and some other gene changes do too (1).
Family history: having a mother or sister with the condition makes it more likely (1).
Autoimmune disease: the immune system can affect ovarian tissue, and autoimmune conditions are more common in this group (1,8).
Cancer treatment: chemotherapy and radiation therapy can both cause it (1,7), which is why guidelines recommend discussing fertility preservation before treatment starts (11).
Getting Diagnosed Takes Two Things
Symptoms alone do not confirm early menopause, because too many other conditions produce the same list. Diagnosis pairs the menstrual pattern with a blood test.
The menstrual history. Clinicians look for cycles that never settled into a regular pattern, or for periods that have been absent for four months or more (2).
A follicle-stimulating hormone test. FSH is the hormone that rises as the ovaries wind down, and a raised result supports the diagnosis. The 2024 European guideline (2) sets the criteria as disordered cycles for at least four months alongside a raised FSH result. It says the test should be repeated after four to six weeks only where the diagnosis is unclear.
Ruling other things out. Pregnancy and thyroid disease both produce overlapping symptoms and get excluded first (2).
Sometimes an AMH test. Anti-Müllerian hormone reflects ovarian reserve and can support the picture. The guideline (2) says it should not be the main test, and (3) notes that no cut-off has been agreed.
Knowing the names of those tests is useful because it lets you ask for the right one rather than describing symptoms and hoping.
The Long-Term Health Picture
This is the part that explains why clinicians treat an early diagnosis as more than a symptom problem. Estrogen does work throughout the body, not only in the reproductive system.
Research on primary ovarian insufficiency reports that women with POI have an increased risk of premature death, mainly from cardiovascular disease. The same review associates POI with decreasing bone mineral density, osteoporosis and increased fracture risk, and with dementia, cognitive decline and Parkinsonism (4).
Bone loss is the most direct of those mechanisms. Falling estrogen drives faster bone breakdown, and that accelerated loss is what can lead to osteoporosis (6). Body composition shifts too, which menopause weight gain covers in full.
Hormone Therapy and What Guidelines Say
Estrogen therapy is the main treatment discussed for this group, and its role here is different from its role in typical menopause.
The estradiol prescribing information lists low estrogen due to primary ovarian failure among its FDA-approved uses, alongside moderate to severe menopausal symptoms and prevention of osteoporosis. So treatment here falls inside the approved label rather than outside it (5).
On duration, the 2024 European POI guideline recommends that women with POI continue hormone therapy until the usual age of menopause (2). A 2025 Korean Society of Menopause guideline reaches the same conclusion, recommending treatment to that age in women with primary ovarian insufficiency whether or not symptoms are present (6).
Check your eligibility to have a licensed provider review your history and symptoms.
Who Should Not Take Estrogen Therapy
Estrogen therapy is not appropriate for everyone, and the label is specific. It also carries a boxed warning, which a provider weighs against your own history rather than in the abstract.
The prescribing information says it should not be taken by anyone with undiagnosed abnormal genital bleeding, a known or suspected history of breast cancer, or a known or suspected estrogen-dependent tumor. It also rules out anyone with active or previous deep vein thrombosis or pulmonary embolism, recent stroke or heart attack, liver disease, or known or suspected pregnancy. The label lists further contraindications too, including known hypersensitivity and known thrombophilic disorders (5).
Where a uterus is present, estrogen is generally paired with progesterone to protect the uterine lining, which is what that medication is FDA-approved to do. Deciding all of this belongs with a provider who has your full history.
Fertility After a Diagnosis
For many people this is the first question, and it deserves a straight answer rather than a hopeful one.
Early menopause reduces fertility substantially, and for most people a POI diagnosis means conceiving without assistance is unlikely (1,3). Spontaneous pregnancy does sometimes happen, because ovarian function in POI can fluctuate rather than stop cleanly (3).
What follows from that is a practical point rather than a medical one. If pregnancy matters to you, raise it with a fertility specialist early rather than later, and treat it as separate from symptom management.
Symptoms Worth a Provider Visit
Some changes are worth raising promptly rather than waiting to see whether they settle.
Bring up periods that have been absent for three months or more when you are not pregnant (12), cycles that have become persistently irregular before 45 (1,8), or hot flashes and night sweats arriving in your thirties or early forties (1,7). Mention a family history of early menopause too, since having a mother or sister with the condition makes it more likely (1).
Seek prompt care for any vaginal bleeding after periods have stopped for a year, because that always needs checking rather than watching (13). Whether any treatment starts, continues or changes is a decision for your prescriber.
The Bottom Line
Early menopause symptoms look much like typical menopause symptoms, and the menstrual change usually arrives first. What separates them is timing: before 45 is early, before 40 is premature, and the research treats those as meaningfully different thresholds (2,3,8).
The diagnosis matters because of what the published literature reports about long-term cardiovascular and bone health (4,6), which is why guidelines address duration of therapy for this group specifically.
A licensed provider on the Mochi Health platform can review your symptoms, order the relevant hormone tests, and discuss whether treatment is appropriate for you. Medications and diagnostic services not included in membership subscription. For the wider picture, how long menopause lasts sets out the usual timeline, and the common questions cover how the platform works.
Check your eligibility to talk to a provider about what you are noticing.
FAQs
What is the youngest age menopause can start?
It can occur in the teens and twenties, although that is uncommon. One review reports roughly 1 in 10,000 women aged 18 to 25 have primary ovarian insufficiency, rising to about 1 in 100 by ages 35 to 40 (9). Any teenager or young woman whose periods have not started or have stopped should be assessed rather than reassured (14).
Can stress cause early menopause?
Stress can disrupt cycles and delay or stop periods without menopause being involved, which is part of why the two get confused. The recognized causes are genetic conditions, autoimmune disease, cancer treatment and family history, with most cases unexplained (1,7). A blood test is what separates the two.
Am I in early menopause or perimenopause?
Perimenopause is the transition, when cycles change but have not stopped. Menopause is the point at which they have stopped for twelve months. Symptoms overlap almost completely, so the distinction comes from your cycle history and testing rather than from how you feel.
Does early menopause shorten your life?
Primary ovarian insufficiency is the form of early menopause that begins before 40. Research on it reports higher rates of several conditions, including coronary heart disease and osteoporosis, along with a raised risk of early death (4). That is an association across populations rather than a prediction for any one person, and it is why guidelines discuss how long treatment should last.
References
MedlinePlus. Primary Ovarian Insufficiency. U.S. National Library of Medicine. Accessed 15 September 2026. https://medlineplus.gov/primaryovarianinsufficiency.html
European Society of Human Reproduction and Embryology, ESHRE Guideline Group on POI. Evidence-based guideline: premature ovarian insufficiency. Human Reproduction Open. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11631070/
Kapoor E. Premature Ovarian Insufficiency, a review. Current Opinion in Endocrine and Metabolic Research. 2023;28:100435. https://pmc.ncbi.nlm.nih.gov/articles/PMC10022589/
Hernández-Angeles C, Castelo-Branco C. Early menopause: a hazard to a woman's health. Indian Journal of Medical Research. 2016;143(4):420-427. https://pmc.ncbi.nlm.nih.gov/articles/PMC4928547/
DailyMed. ESTRADIOL tablet, prescribing information including the boxed warning and contraindications. U.S. National Library of Medicine. Accessed 15 September 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=37f3094c-f02d-4a9c-8e30-2c4752bc62ed
Kim Y, Cho MK, Chung YJ, et al. The 2025 Menopausal Hormone Therapy Guidelines, Korean Society of Menopause. Journal of Menopausal Medicine. 2025;31(2):53-84. https://pmc.ncbi.nlm.nih.gov/articles/PMC12438153/
Mayo Clinic. Primary ovarian insufficiency, symptoms and causes. Accessed 15 September 2026. https://www.mayoclinic.org/diseases-conditions/premature-ovarian-failure/symptoms-causes/syc-20354683
Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, et al. Autoimmune Diseases in Patients with Premature Ovarian Insufficiency, Our Current State of Knowledge. International Journal of Molecular Sciences. 2021;22(5):2594. https://pmc.ncbi.nlm.nih.gov/articles/PMC7961833/
Rudnicka E, Kruszewska J, Klicka K, et al. Premature ovarian insufficiency, aetiopathology, epidemiology, and diagnostic evaluation. Przegląd Menopauzalny (Menopause Review). 2018;17(3):105-108. https://pmc.ncbi.nlm.nih.gov/articles/PMC6196779/
Golezar S, Ramezani Tehrani F, Khazaei S, Ebadi A, Keshavarz Z. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric. 2019. https://pubmed.ncbi.nlm.nih.gov/30829083/
Anderson RA, Amant F, Braat D, et al. ESHRE guideline: female fertility preservation. Human Reproduction Open. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7666361/
Cleveland Clinic. Primary Ovarian Insufficiency (POI). Accessed 29 September 2026. https://my.clevelandclinic.org/health/diseases/17963-primary-ovarian-insufficiency
Mayo Clinic. Bleeding after menopause: a concern? Accessed 29 September 2026. https://www.mayoclinic.org/diseases-conditions/menopause/expert-answers/bleeding-after-menopause/faq-20058396
Cipres DT, Gordon CM. Primary ovarian insufficiency, bone health, and other outcomes in adolescents. Obstetrics and Gynecology Clinics of North America. 2024;51:663-678. https://pmc.ncbi.nlm.nih.gov/articles/PMC11566969/
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. Estradiol and progesterone require a written prescription from a licensed provider. Speak with a provider to determine if estradiol or progesterone is appropriate for you. Estradiol is FDA-approved for moderate to severe menopausal symptoms, for low estrogen due to primary ovarian failure, and for the prevention of osteoporosis, and it carries a boxed warning that a provider will discuss with you. Individual results are not guaranteed and may vary from person to person. All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.
More articles
Read next
For iOS & Android
